Literature DB >> 9124556

Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretin-null mice.

J A Palha1, M T Hays, G Morreale de Escobar, V Episkopou, M E Gottesman, M J Saraiva.   

Abstract

As part of a study on tissue uptake of thyroxine (T4) in a transthyretin (TTR)-null mouse strain, kinetic parameters of thyroxine metabolism in wild-type mice under normal physiological conditions are presented. Kinetic analysis of injected [(125)I]T4 showed that TTR-null mutants have markedly increased [(125)I]T4 transfer rate constants from plasma to the fast-exchange compartments of liver and kidney and from fast to slow kidney compartments. Transfer rates from plasma to brain, testes, and fat were little affected. The T4 tissue content in the mutants was greatly reduced in brain but relatively normal in liver and kidney. No major changes were observed in brain 3,3',5-triiodothyronine concentrations, suggesting that availability of this hormone is not markedly altered in the mutant mice. The low T4 brain content probably reflects the absence of T4-TTR complexes in the mutant choroid plexus and cerebrospinal fluid. This study indicates that TTR is not essential for T4 tissue uptake or for T4 to reach the brain across the choroid plexus-cerebrospinal fluid and/or blood-brain barriers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124556     DOI: 10.1152/ajpendo.1997.272.3.E485

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

Review 1.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

2.  Is the kidney a major storage site for thyroxine as thyroxine glucuronide?

Authors:  Maarten Buitendijk; Valerie Anne Galton
Journal:  Thyroid       Date:  2011-12-16       Impact factor: 6.568

3.  Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.

Authors:  Zoran Redzic
Journal:  Fluids Barriers CNS       Date:  2011-01-18

4.  Delayed development of specific thyroid hormone-regulated events in transthyretin null mice.

Authors:  Julie A Monk; Natalie A Sims; Katarzyna M Dziegielewska; Roy E Weiss; Robert G Ramsay; Samantha J Richardson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-10-23       Impact factor: 4.310

5.  Substrate specificity of transthyretin: identification of natural substrates in the nervous system.

Authors:  Márcia A Liz; Carolina E Fleming; Ana F Nunes; Maria R Almeida; Fernando M Mar; Youngchool Choe; Charles S Craik; James C Powers; Matthew Bogyo; Mónica M Sousa
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

6.  Increased expression of axogenesis-related genes and mossy fibre length in dentate granule cells from adult HuD overexpressor mice.

Authors:  Nora I Perrone-Bizzozero; Daniel C Tanner; Joanna Mounce; Federico Bolognani
Journal:  ASN Neuro       Date:  2011       Impact factor: 4.146

7.  Choroid plexus transport: gene deletion studies.

Authors:  Richard F Keep; David E Smith
Journal:  Fluids Barriers CNS       Date:  2011-11-04

Review 8.  Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?

Authors:  Xinyi Li; Joel N Buxbaum
Journal:  Mol Neurodegener       Date:  2011-11-23       Impact factor: 14.195

Review 9.  Transport of thyroid hormones via the choroid plexus into the brain: the roles of transthyretin and thyroid hormone transmembrane transporters.

Authors:  Samantha J Richardson; Roshen C Wijayagunaratne; Damian G D'Souza; Veerle M Darras; Stijn L J Van Herck
Journal:  Front Neurosci       Date:  2015-03-03       Impact factor: 4.677

10.  Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.

Authors:  Laura Zemany; Sanjay Bhanot; Odile D Peroni; Susan F Murray; Pedro M Moraes-Vieira; Angela Castoldi; Prasad Manchem; Shuling Guo; Brett P Monia; Barbara B Kahn
Journal:  Diabetes       Date:  2014-12-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.